ロード中...
Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization
BACKGROUND: Neuroimaging measures and chemical biomarkers may be important indices of clinical progression in normal aging and mild cognitive impairment (MCI) and need to be evaluated longitudinally. OBJECTIVE: To characterize cross-sectionally and longitudinally clinical measures in normal controls...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Academy of Neurology
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2809036/ https://ncbi.nlm.nih.gov/pubmed/20042704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181cb3e25 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|